ArticleVaccine2018

In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.

Ria Mulherkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.